美国凯撒医疗要在商场内开诊所,杭州Medical Mall开业,商场+医疗诊所风口已至?

2017-09-28 佚名 高端私人医生服务

这两天,杭州Medical Mall(医疗商城)这种模式的出现在医疗圈和地产圈开始刷屏,让很多人第一次把商场和医疗机构紧密联系起来,尽管之前很多人在商场里也见过各种医疗机构。


这两天,杭州Medical Mall(医疗商城)这种模式的出现在医疗圈和地产圈开始刷屏,让很多人第一次把商场和医疗机构紧密联系起来,尽管之前很多人在商场里也见过各种医疗机构。

浙江省卫计委批复同意的Medical Mall位于杭州大厦501城市生活广场,1层-5层为购物区,6层-20层全为医疗商场。消费者可以在Medical Mall体验消费购物与医疗服务的多维体验,以此避免了单纯去医院的焦虑感。
杭州大厦501城市生活广场


通俗的说“Medical Mall医疗商场”,就是一家由多个医疗机构“拼”起来的医疗中心。“医疗商场”共12层,目前入驻了12家医疗机构,9-15层每层各两家机构,分别为爱丁优生助孕、杏康门诊;方回春堂、太学眼科;仁树耳鼻喉科、启代妇儿诊所;颜术医疗美容、艾维口腔(西子国际门诊部);张强医生集团思俊外科诊所、唯儿诺儿科;16层为杭州口腔医院骋东门诊部、三叶儿童口腔(隶属于同一家医疗集团);17-22层是由全程健康管理中心和邵逸夫医院联合运营的“邵逸夫国际医疗中心”。

网上关于杭州Medical Mall(医疗中心)的介绍和报道很多了,感兴趣的可以点击以下两条新闻了解 1、 实地探访(多图)全国首个Medical Mail(医疗中心)  2、原版香港诊所大楼Medical Mall(多图参观),为何被国家卫计委点赞推荐?

其实这种模式在新加坡、美国、香港、日本等地早已有之,并有很多成功案例。



日前,美国最大的医疗集团Kaiser Permanente(凯撒医疗集团,以下简称凯撒)和Target Corporation宣布,将在南加州的Target零售商店推出31个凯撒零售诊所。

通过这次合作,凯撒和Target将建立“Target Clinic,Provided by Kaiser Permanente”诊所品牌(以下简称Target诊所),由凯撒负责医疗方面的服务,向其会员和Target客人提供零售店内诊所服务。

目前已运营4家Target诊所  未来三年将开放31家

该计划建立在两个大品牌现有合作上。早在2014年开始,Target公司已经与凯撒医疗集团达成合作,计划为Target零售商店的消费者提供便捷、高质量的健康解决方案。

其中,凯撒集团将为新诊所配备许可护士和持照职业护士,并将通过远程医疗协商提供医生。Target诊所将为客人提供广泛的服务。包括:儿科护理; 妇女保健; 监测和治疗慢性病,包括糖尿病胆固醇高血压; 基础皮肤科服务; 治疗轻度疾病,包括喉咙痛,疫苗接种,窦痛,耳痛,哮喘,感冒和流感。

凯撒的综合护理服务系统旨在为客户提供优先级的预防保健,从基础的医疗保健着手,因此针对特殊的访客体验,将诊所铺设在Target零售商店内。也就是说在南加州地区的居民可以在方便、信赖和熟悉的环境中接受高质量的医疗保健。

“从每年都需要接受注射的流感疫苗到针对小孩的喉咙痛的保健治疗,我们四家试点商店的客人告诉我们,他们希望在Target商店营业期间,获得由凯撒提供的高质量保健服务。”

目前,有4家诊所已筹建完成,此外今年11月,还将开放另外4家Target诊所,其余在此次宣布的31家计划之内的诊所将在未来三年内在南加州的Target商店全面开放。

共享资源,凯撒和Target一次双赢的合作

Target的健康部高级总监Steve Lafferty表示:“扩大Target 诊所所在地的数量使得这些产品可以提供给更多的南加州客人,并为凯撒的会员提供了选择Target的更多理由,在Target既可以享受到医疗服务,又可以拥有简单、方便和令人振奋的购物体验。”

凯撒基金会健康计划和医院公司总经理朱利·米勒·皮普斯(Julie Miller-Phipps)表示:“这是一次成功的合作,其重点是医疗服务质量和便利性,我们很自豪地扩大我们现有的努力,为南加州的更多Target客户提供价格合理,优质的医疗保健。“

同时经营零售药房诊所的CVS Health已在其旗下“零售诊所”MinuteClinic向凯撒提供常规药品服务,以支持其现有的4个Target诊所。患者在Target诊所就医后,符合条件的凯撒会员将能够在Target诊所的CVS药房获得所需的药品。

MinuteClinic的高级副总裁兼执行总监Sharon Vitti说:“CVS药剂和MinuteClinic很高兴在这种独特的保健关系中发挥作用。“CVS Pharmacy和MinuteClinic都有良好的记录,为病人提供一流的护理,我们期待着通过我们在Target商店的存在为南加州居民提供药学需求。”

目前,Target诊所将接受现金及信用卡,并接入大范围的健康保险计划,方便客户享受服务。

零售+医疗风口已至?

在全世界范围内,由UBER引领的共享经济风口正在包括初级保健服务在内的许多领域发力,在美国,Target并不是唯一一个进入医疗保健行业的零售巨头。

以沃尔玛为例,早在2015年,在在奥巴马医改的医保交易平台政策的影响下,初级医疗保健服务系统在美国数百万居民中流行,沃尔玛借此契机,在自己规模较大的商场内开设了数个初级医疗保健诊所(Primary Care Clinics)。

目前,沃尔玛已经拥有了超过100家零售店内的诊所,并与QuadMed公司达成了合作。沃尔玛正在努力进行品牌化推广,试图把这些全新的企业旗下诊所变成初级医疗保健服务的“一站式商店”。这些诊所在工作日每天营业12小时,周末营业8小时,为新加入医保行业的投保人提供全新而又便利的护理服务。

此外,2015年,美国Whole Foods公司也涉足医疗健康行业,在美国地区建立Whole Foods健康诊所,为消费者和公司员工提供疾病咨询和慢性病治疗方案等服务。

零售诊所被视为一种新方法,可以及时提供较便宜的护理,并大大缩短传统就诊时在拥挤候诊室等待医生的时间,提供快捷、便利的服务。

无论是零售药店设立诊所还是传统零售商的诊所铺设,零售业进入医疗健康行业这一趋势无论是在基层医疗领域或是推动分级诊疗政策的实施而言,于我国都有借鉴意义。零售医疗对传统医疗连锁而言,会不会是一次冲击?美国的零售商纷纷涉足初级医疗保健服务领域,医疗健康行业是否将再次迎来一波转型潮?这是动脉网接下来会持续关注的领域及新趋势。

关于Target Corporation
明尼阿波利斯的Target 公司(纽约证券交易所代码:TGT)拥有1816家商店和Target.com在线购物网站。自1946年以来,Target已经将社会的利润提高了5%,目前平均每周盈利数百万美元。

关于Kaiser Permanente
凯撒医疗集团(Kaiser Permanente)成立于1945年,被公认为美国领先的医疗保健提供者和非营利健康计划之一。集团致力于帮助塑造未来的医疗保健,其使命是提供优质、价格合理的医疗服务,并改善其会员和所服务的社区健康状况。目前凯撒在全美八个州和哥伦比亚特区服务1180万名成员。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1858787, encodeId=c1e11858e877a, content=<a href='/topic/show?id=e0a9593596' target=_blank style='color:#2F92EE;'>#DIC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5935, encryptionId=e0a9593596, topicName=DIC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f7770, createdName=jeanqiuqiu, createdTime=Thu Oct 19 07:48:00 CST 2017, time=2017-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1311023, encodeId=b4dc131102332, content=<a href='/topic/show?id=39be91564e5' target=_blank style='color:#2F92EE;'>#诊所#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91564, encryptionId=39be91564e5, topicName=诊所)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c805395, createdName=ycmayy, createdTime=Sat Sep 30 01:48:00 CST 2017, time=2017-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1329021, encodeId=ec21132902113, content=<a href='/topic/show?id=bb96232801' target=_blank style='color:#2F92EE;'>#ALL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2328, encryptionId=bb96232801, topicName=ALL)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/C2EFD5CFB07FE291138AD4FD0C98E3DE/100, createdBy=e3d52500031, createdName=膀胱癌, createdTime=Sat Sep 30 01:48:00 CST 2017, time=2017-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1533560, encodeId=faad1533560e5, content=<a href='/topic/show?id=7583114e529' target=_blank style='color:#2F92EE;'>#Medical#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11475, encryptionId=7583114e529, topicName=Medical)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cbe912466517, createdName=海豹, createdTime=Sat Sep 30 01:48:00 CST 2017, time=2017-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1608071, encodeId=c0ad16080e167, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sat Sep 30 01:48:00 CST 2017, time=2017-09-30, status=1, ipAttribution=)]
    2017-10-19 jeanqiuqiu
  2. [GetPortalCommentsPageByObjectIdResponse(id=1858787, encodeId=c1e11858e877a, content=<a href='/topic/show?id=e0a9593596' target=_blank style='color:#2F92EE;'>#DIC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5935, encryptionId=e0a9593596, topicName=DIC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f7770, createdName=jeanqiuqiu, createdTime=Thu Oct 19 07:48:00 CST 2017, time=2017-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1311023, encodeId=b4dc131102332, content=<a href='/topic/show?id=39be91564e5' target=_blank style='color:#2F92EE;'>#诊所#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91564, encryptionId=39be91564e5, topicName=诊所)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c805395, createdName=ycmayy, createdTime=Sat Sep 30 01:48:00 CST 2017, time=2017-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1329021, encodeId=ec21132902113, content=<a href='/topic/show?id=bb96232801' target=_blank style='color:#2F92EE;'>#ALL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2328, encryptionId=bb96232801, topicName=ALL)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/C2EFD5CFB07FE291138AD4FD0C98E3DE/100, createdBy=e3d52500031, createdName=膀胱癌, createdTime=Sat Sep 30 01:48:00 CST 2017, time=2017-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1533560, encodeId=faad1533560e5, content=<a href='/topic/show?id=7583114e529' target=_blank style='color:#2F92EE;'>#Medical#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11475, encryptionId=7583114e529, topicName=Medical)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cbe912466517, createdName=海豹, createdTime=Sat Sep 30 01:48:00 CST 2017, time=2017-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1608071, encodeId=c0ad16080e167, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sat Sep 30 01:48:00 CST 2017, time=2017-09-30, status=1, ipAttribution=)]
    2017-09-30 ycmayy
  3. [GetPortalCommentsPageByObjectIdResponse(id=1858787, encodeId=c1e11858e877a, content=<a href='/topic/show?id=e0a9593596' target=_blank style='color:#2F92EE;'>#DIC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5935, encryptionId=e0a9593596, topicName=DIC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f7770, createdName=jeanqiuqiu, createdTime=Thu Oct 19 07:48:00 CST 2017, time=2017-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1311023, encodeId=b4dc131102332, content=<a href='/topic/show?id=39be91564e5' target=_blank style='color:#2F92EE;'>#诊所#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91564, encryptionId=39be91564e5, topicName=诊所)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c805395, createdName=ycmayy, createdTime=Sat Sep 30 01:48:00 CST 2017, time=2017-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1329021, encodeId=ec21132902113, content=<a href='/topic/show?id=bb96232801' target=_blank style='color:#2F92EE;'>#ALL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2328, encryptionId=bb96232801, topicName=ALL)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/C2EFD5CFB07FE291138AD4FD0C98E3DE/100, createdBy=e3d52500031, createdName=膀胱癌, createdTime=Sat Sep 30 01:48:00 CST 2017, time=2017-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1533560, encodeId=faad1533560e5, content=<a href='/topic/show?id=7583114e529' target=_blank style='color:#2F92EE;'>#Medical#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11475, encryptionId=7583114e529, topicName=Medical)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cbe912466517, createdName=海豹, createdTime=Sat Sep 30 01:48:00 CST 2017, time=2017-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1608071, encodeId=c0ad16080e167, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sat Sep 30 01:48:00 CST 2017, time=2017-09-30, status=1, ipAttribution=)]
    2017-09-30 膀胱癌
  4. [GetPortalCommentsPageByObjectIdResponse(id=1858787, encodeId=c1e11858e877a, content=<a href='/topic/show?id=e0a9593596' target=_blank style='color:#2F92EE;'>#DIC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5935, encryptionId=e0a9593596, topicName=DIC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f7770, createdName=jeanqiuqiu, createdTime=Thu Oct 19 07:48:00 CST 2017, time=2017-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1311023, encodeId=b4dc131102332, content=<a href='/topic/show?id=39be91564e5' target=_blank style='color:#2F92EE;'>#诊所#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91564, encryptionId=39be91564e5, topicName=诊所)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c805395, createdName=ycmayy, createdTime=Sat Sep 30 01:48:00 CST 2017, time=2017-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1329021, encodeId=ec21132902113, content=<a href='/topic/show?id=bb96232801' target=_blank style='color:#2F92EE;'>#ALL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2328, encryptionId=bb96232801, topicName=ALL)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/C2EFD5CFB07FE291138AD4FD0C98E3DE/100, createdBy=e3d52500031, createdName=膀胱癌, createdTime=Sat Sep 30 01:48:00 CST 2017, time=2017-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1533560, encodeId=faad1533560e5, content=<a href='/topic/show?id=7583114e529' target=_blank style='color:#2F92EE;'>#Medical#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11475, encryptionId=7583114e529, topicName=Medical)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cbe912466517, createdName=海豹, createdTime=Sat Sep 30 01:48:00 CST 2017, time=2017-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1608071, encodeId=c0ad16080e167, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sat Sep 30 01:48:00 CST 2017, time=2017-09-30, status=1, ipAttribution=)]
    2017-09-30 海豹
  5. [GetPortalCommentsPageByObjectIdResponse(id=1858787, encodeId=c1e11858e877a, content=<a href='/topic/show?id=e0a9593596' target=_blank style='color:#2F92EE;'>#DIC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5935, encryptionId=e0a9593596, topicName=DIC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f7770, createdName=jeanqiuqiu, createdTime=Thu Oct 19 07:48:00 CST 2017, time=2017-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1311023, encodeId=b4dc131102332, content=<a href='/topic/show?id=39be91564e5' target=_blank style='color:#2F92EE;'>#诊所#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91564, encryptionId=39be91564e5, topicName=诊所)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c805395, createdName=ycmayy, createdTime=Sat Sep 30 01:48:00 CST 2017, time=2017-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1329021, encodeId=ec21132902113, content=<a href='/topic/show?id=bb96232801' target=_blank style='color:#2F92EE;'>#ALL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2328, encryptionId=bb96232801, topicName=ALL)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/C2EFD5CFB07FE291138AD4FD0C98E3DE/100, createdBy=e3d52500031, createdName=膀胱癌, createdTime=Sat Sep 30 01:48:00 CST 2017, time=2017-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1533560, encodeId=faad1533560e5, content=<a href='/topic/show?id=7583114e529' target=_blank style='color:#2F92EE;'>#Medical#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11475, encryptionId=7583114e529, topicName=Medical)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cbe912466517, createdName=海豹, createdTime=Sat Sep 30 01:48:00 CST 2017, time=2017-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1608071, encodeId=c0ad16080e167, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sat Sep 30 01:48:00 CST 2017, time=2017-09-30, status=1, ipAttribution=)]